Prudent Man Advisors, LLC Sanofi Transaction History

Prudent Man Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$50.95 - $55.2 $8,814 - $9,549	-173 Reduced 3.31%	5,051 $270,000
Q4 2022 Feb 13, 2023	BUY	$38.86 - $48.55 $203,004 - $253,625	5,224 New	5,224 $253,000
Q2 2022 Aug 05, 2022	SELL	$48.99 - $57.46 $200,761 - $235,471	-4,098 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$47.07 - $52.35 $38,503 - $42,822	-818 Reduced 16.64%	4,098 $205,000
Q2 2021 Aug 03, 2021	BUY	$49.36 - $54.25 $1,826 - $2,007	37 Added 0.76%	4,916 $259,000
Q1 2021 May 14, 2021	SELL	$45.46 - $50.51 $181 - $202	-4 Reduced 0.08%	4,879 $241,000
Q3 2020 Nov 16, 2020	SELL	$49.47 - $53.77 $3,759 - $4,086	-76 Reduced 1.53%	4,883 $245,000
Q2 2020 Aug 12, 2020	BUY	$42.91 - $52.5 $212,790 - $260,347	4,959 New	4,959 $253,000

822

268M

1.9M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $120B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Prudent Man Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Prudent Man Advisors, LLC with notifications on news.